ANAEROBIC FERMENTATION
& ESTERIFICATION OF
BIOMASS TO PRODUCE
AT INDUSTRIAL SCALE
FINE CHEMICALS
WHAT IS AFTER-BIOCHEM?
The AFTER-BIOCHEM project is aiming to develop the first all-in-one biorefinery within the « CHEMESIS » chemical platform sited in Carling Saint-Avold, France. It will create multiple value chains based on the transformation of sugar industry’s co-products as well as other non-food biomass feedstocks into bio-based and natural molecules for various applications.
AFTER-BIOCHEM brings together at different stages of the value chain teams 12 partners from 5 European countries. The project will be carried out over 48 months, from May 2020 to April 2024, with an overall budget of € 33M including € 20M funding from the European Union’s Horizon 2020 research and innovation programme and the Bio Based Industries Consortium.
Latest news
AFTER-BIOCHEM in OAG
AFTER-BIOCHEM is in the January edition of Open Access Government! The project AFTER-BIOCHEM will allow the sustainable replication of the first of its kind AFYREN-NEOXY biorefinery which is fully in line with the contribution to the Sustainable Development Goals...
Construction of the biorefinery
Construction of AFYREN NEOXY, a € 80 million biorefinery that will produce 16 thousand tons of organic acids annually from 2020, is about to begin! AFYREN, a French biotech company has raised more than € 80 million with Bpifrance, the European Investment Bank, Total...
AFTER-BIOCHEM WEBSITE LAUNCH
AFTER-BIOCHEM WEBSITE LAUNCH AND SOCIAL MEDIA PRESENCE AFTER-BIOCHEM Project and its 12 partners are glad to launch their website and to be on Twitter & LinkedIn ! There, you will find all the information the project wishes to share with its community. Looking...
Follow us on Twitter
Be aware of all the news, events to come, results and much more!
ℹ️ Interested in AFTER-BIOCHEM's contribution to the current global context?
💡In @OpenAccessGov we highlight the projects' contribution to UN #SDGs, EU current policy as the #GreenDeal and the Chemical Strategy for #Sustainability
➡️To know more: https://t.co/IH67VB3m8P https://t.co/sA4cTsNnYj
Partners
